FDA
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
-
-
-
-
-
-
-
Madrigal licenses siRNA asset from Arrowhead for MASH treatment
-
-
-
-
-
-
-
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
-
-
-
-
-
-
-
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2025 Financial Results and Host Webcast on February 19, 2026
-
-
-
-
-
-
-
Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
330,173 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

